media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Bharat Immunological & Biologicals Corporation Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]44.6178.3985.3366.8483.65
Total Operating Revenues44.6178.3985.3366.8483.65
      
Other Income2.801.101.681.184.22
Total Revenue47.4179.4987.0168.0287.87
      
EXPENSES     
Cost Of Materials Consumed33.0459.1961.0668.9584.28
Changes In Inventories Of FG,WIP And Stock-In Trade5.950.4420.15-12.99-13.55
Employee Benefit Expenses15.3213.8514.4411.379.78
Finance Costs7.045.594.784.742.00
Depreciation And Amortisation Expenses0.150.210.240.240.28
Other Expenses8.779.8910.569.9112.46
Total Expenses70.2689.18111.2282.2295.24
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-22.85-9.69-24.21-14.20-7.37
      
Profit/Loss Before Tax-22.85-9.69-24.21-14.20-7.37
      
Tax Expenses-Continued Operations     
Current Tax-5.790.000.000.000.00
Deferred Tax0.00-0.93-6.10-3.99-1.58
Total Tax Expenses-5.79-0.93-6.10-3.99-1.58
Profit/Loss After Tax And Before ExtraOrdinary Items-17.06-8.75-18.11-10.21-5.79
      
Profit/Loss From Continuing Operations-17.06-8.75-18.11-10.21-5.79
      
Profit/Loss For The Period-17.06-8.75-18.11-10.21-5.79
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-3.95-2.03-4.19-2.36-1.57
Diluted EPS (Rs.)-3.95-2.03-4.19-2.36-1.57
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]44.61
Total Operating Revenues44.61
Other Income2.80
Total Revenue47.41
EXPENSES 
Cost Of Materials Consumed33.04
Changes In Inventories Of FG,WIP And Stock-In Trade5.95
Employee Benefit Expenses15.32
Finance Costs7.04
Depreciation And Amortisation Expenses0.15
Other Expenses8.77
Total Expenses70.26
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-22.85
Profit/Loss Before Tax-22.85
Tax Expenses-Continued Operations 
Current Tax-5.79
Deferred Tax0.00
Total Tax Expenses-5.79
Profit/Loss After Tax And Before ExtraOrdinary Items-17.06
Profit/Loss From Continuing Operations-17.06
Profit/Loss For The Period-17.06
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-3.95
Diluted EPS (Rs.)-3.95